Unicycive Therapeutics Inc.

NASDAQ: UNCY
Share price (3/21/25): $0.68
Market cap (3/21/25): $77.1 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 09/30/24 Q3

ended 06/30/24 Q2

ended 03/31/24 Q1

ended 12/31/23 FY 2023

ended 09/30/23 Q3

Prospectuses and Registrations Filter

Shelf registration

Updated info for already-effective prospectus

Prospectus supplement

Shelf registration

Exempt offering of securities

Ownership Filter

Aggarwal Gaurav

Ra Capital Management, L.P.

Great Point Partners LLC

Walleye Capital LLC

Nantahala Capital Management, LLC

News Filter

Announces Third Quarter 2024 Financial Results and Provides Business Update

Announces U.S. FDA Acceptance of the New Drug Application (NDA) for Oxylanthanum Carbonate (OLC) for the Treatment of Hyperphosphatemia in Patients With Chronic Kidney Disease on Dialysis

Announces Second Quarter 2024 Financial Results and Provides Business Update

Proxies Filter

Additional info about upcoming vote

Additional info about upcoming vote

Definitive proxy

Preliminary proxy

Additional info about upcoming vote

Other Filter

Notice of effectiveness

Correspondence with the SEC

Notice of effectiveness

Letter from the SEC

Notice of effectiveness